key: cord-0858028-plz45gjg authors: Wimberly, Courtney E.; Towry, Lisa; Davis, Elizabeth; Johnston, Emily E.; Walsh, Kyle M. title: SARS‐CoV‐2 vaccine acceptability among caregivers of childhood cancer survivors date: 2021-11-17 journal: Pediatr Blood Cancer DOI: 10.1002/pbc.29443 sha: 2dd670ee3b7782563ba30d4975b51cf8663a9f4b doc_id: 858028 cord_uid: plz45gjg OBJECTIVE: To explore willingness/hesitancy to vaccinate self and children against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) among caregivers of childhood cancer survivors (CCS). METHODS: A 19‐question survey was sent to caregivers of CCS and completed between February 25 and April 13, 2021. Logistic regression was used to investigate relationships between willingness/hesitancy to vaccinate (a) self and (b) CCS, and demographic variables, confidence in the government and medical community's responses to coronavirus disease 2019 (COVID‐19), and factors specific to the CCS community (e.g., previous participation in an investigational therapeutic trial). RESULTS: Caregivers (6% male) from 130 unique families completed the survey. Mean CCS age at survey was 15 years (SD 6.4). Mean CCS age at diagnosis was 4.3 years (SD 4.3). Mean time from CCS diagnosis to survey completion was 10 years (SD 6.2). Twenty‐one percent of caregivers expressed hesitancy to vaccinate themselves and 29% expressed hesitancy to vaccinate their CCS. Caregivers expressing confidence in the federal government's response to COVID‐19 were six‐fold likelier to express willingness to self‐vaccinate (p < .001) and were three‐fold likelier to express willingness to vaccinate their CCS (p = .011). Qualitative analysis of free‐text responses revealed three general themes, including (a) confidence in science, medicine, and vaccination as a strategy for health promotion, (b) confidence in SARS‐CoV‐2 vaccination and belief that CCS are at greater risk of COVID‐19 complications, and (c) concerns about the swiftness of COVID‐19 vaccine development and insufficient safety/efficacy data in children and CCS. CONCLUSIONS: Results underscore the need for COVID‐19 vaccination education and outreach, even among families highly engaged with the medical community, and emphasize the importance of updating these families as relevant data emerge from vaccine trials and registries. Broad acceptance of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine is considered an integral strategy for mitigating the coronavirus disease 2019 (COVID- 19) pandemic. Several efficacious vaccines have been authorized by the United States Food and Drug Administration (FDA) for emergency use in adults, [1] [2] [3] Pfizer-BioNTech vaccine is authorized for use in anyone aged 12 and older. 4 Across the United States, vaccine uptake continues to steadily increase, 5 yet COVID-19 vaccination uptake remains lower among certain populations, including those with lower socioeconomic status, racial and ethnic minorities, and individuals reporting low trust in health care and government institutions. 6 Vaccine acceptability among caregivers of childhood cancer survivors (CCS) is poorly understood and may differ from the general population due to the prevalence of chronic, comorbid health conditions and compromised immune status in CCS. [7] [8] [9] [10] [11] [12] [13] Immunosuppressed individuals and those with other chronic conditions, like cancer, may have uncertainties about COVID-19 vaccine efficacy, safety, and potential side effects due to limited vaccine trial data specific to this patient population. Studies in adults with cancer have reported overall positive attitudes toward COVID-19 vaccination and a general willingness to be vaccinated, though participants expressed concerns about the vaccine development process, its safety, and its efficacy. 14, 15 Similar willingness has been reported in parents of young children, but these studies note that the final decision to vaccinate may be influenced by the recommendations of health professionals 16, 17 and of governmental health organizations. 6 We previously partnered with the Alex's Lemonade Stand Foundation (ALSF) to assess the impact of COVID-19 on US-based caregivers of CCS, identifying significant disruptions to daily life, continuity of medical care, and household finances that were associated with substantial emotional distress. 18 Many caregivers expressed hopefulness about the future-a sentiment that was associated with self-reported confidence in the government response to COVID-19 and the timeline for vaccine development. Although COVID-19 vaccine acceptability has been studied in the general population, in parents/guardians, and in adults with cancer, there remain no specific data on vaccine acceptability among caregivers of CCS. Compared to the general population, CCS families are more deeply integrated in the medical system due to medical complexities, and many CCS have participated in therapeutic clinical trials. 19, 20 As a result, relationships between demographic/clinical factors and vaccine acceptability may be modified in this population due to differing levels of confidence in medical systems and more frequent interactions with providers. We have conducted a follow up to our prior COVID-19 survey, 18 this time focusing on acceptability of COVID-19 vaccination in CCS families. We assessed willingness/hesitancy to vaccinate self and children among caregivers of CCS and report relationships between demographic factors, confidence in the government and medical community's responses to COVID-19, and factors specific to the CCS community (e.g., previous participation in an experimental therapeutic trial) to provide insight into caregiver perceptions on vaccine acceptability and potential barriers to broad vaccine uptake in this atrisk population. Survey questions explored ways in which the COVID-19 outbreak continued to affect the child's medical care, steps respondents were still taking to reduce SARS-CoV-2 infection risks, primary sources of information on COVID-19, and indicators of mental/somatic wellbeing, as previously described and published. 18 This portion of the survey included multiple-choice, Likert-type, and free-text questions adapted from a COVID-related update to the "Parenting Across Cultures" survey-a longitudinal study of mothers, fathers, and youth in nine countries. 21 Additional Likert-type and free-text questions related to COVID-19 vaccine acceptability were adapted from a published mixed methods investigation of parent/guardian perceptions of the acceptability of a COVID-19 vaccine. 6 The Wave 2 questionnaire contained 23 nonrandomized questions, which appeared on the screen one question at a time, with the option to return to prior questions (full Wave 2 questionnaire appears in Supporting Resource S1 Both dependent and independent variables were derived from survey questions. Dependent variables included measures of caregiver willingness to vaccinate themselves and their CCS during the COVID-19 pandemic, as well as a binary indicator of COVID-19 vaccination status at the time of survey. To measure vaccine acceptability, we asked, "When the COVID-19 vaccine becomes available to you, will you accept the vaccine for yourself?" and "When the COVID-19 vaccine becomes available to [your CCS], will your child receive the vaccine?" Four response options were included for both questions: "yes definitely," "unsure but leaning toward yes," "unsure but leaning toward no," "definitely no." We included a fifth response option ("already vaccinated") for participants and CCS who had already received a COVID-19 vaccination at the time of survey completion. For analysis, answers to self and CCS vaccine willingness were dichotomized into binary variables for "yes, will vaccinate" and "no, will not vaccinate" and used as dependent variables. Caregivers and CCS who had already been vaccinated were included in the "yes, will vaccinate" group. An additional binary indicator of caregivers that had already been vaccinated at the time of survey completion was constructed and used as an additional dependent variable. Independent variables included the child's treatment status ("surveillance/follow-up care" vs. "treatment/surveillance completed"), child's cancer type, the caregiver-respondent's sex, child's age at survey completion, annual household income at MCC registration, whether the child had ever received treatment as part of a clinical trial, caregiver confidence in the federal government's response to COVID-19, caregiver confidence in their state/local governments' responses to COVID-19, caregiver confidence in hospitals' and physicians' responses to COVID-19, and several sources of COVID-19 information including governmental organizations, social media, cancer care professionals, and academic centers. Household income was collapsed to three levels (<$50,000, $50,000-$100,000, >$100,000) for analysis. Additional data collected in the survey but not included in regression models either did not show substantial variability across respondents or were collected for purposes outside the scope of this analysis of COVID-19 vaccine acceptability (e.g., an ALSF COVID-19 needs assessment, longitudinal changes in psychosocial impacts). Descriptive statistics were calculated for each independent and dependent variable. Univariate analyses were used to assess whether participants who responded to Wave 1 only differed from those who responded to both Wave 1 and Wave 2. Logistic regression was used to assess the relationship between our primary outcomes of inter- investigators met interactively to refine themes and develop a codebook for qualitative analysis. 22 Free-text responses were coded in parallel and differences were resolved through discussion. 23 Interrater reliability was calculated as the percent agreement (total number of ratings divided by the total number in agreement) between the investigators coding free-text responses (Courtney E. Wimberly, Kyle M. Walsh). Final themes were reviewed and supportive responses deidentified for publication. Nearly 80% of caregiver-respondents expressed willingness to receive the COVID-19 vaccine for themselves, including 26% who had already been vaccinated, 45% who indicated that they would definitely receive the vaccine when it became available to them, and 8% who were unsure but "leaning toward yes" ( In multivariable logistic regression models, older CCS age at survey completion was significantly associated with the caregiver's willingness to give the vaccine to their CCS (p = .028) but not to receive the vaccine themselves (p = .073) ( Table 3) . Additionally, the odds of caregiver willingness to self-vaccinate against COVID-19 increased by approximately 5.8% (95% CI = 1.92-17.72, p = 1.9 × 10 -3 ) with each one-unit increase (e.g., moving from "strongly disagree" to "some- All else held constant, the odds caregivers were already vaccinated against COVID-19 at time of survey increased by approximately 2% (95% CI = 0.94-4.44, p = .015) for each one-unit increase in confidence in the federal government's response to COVID-19, and by approximately 2.5% (95% CI = 0.92-6.75, p = .073) for each one-unit increase in confidence in the hospitals' and doctors' offices responses to the pandemic. However, these associations did not reach significance. Caregiver sex, caregiver race/ethnicity, household income, prior CCS participation in a therapeutic clinical trial, and CCS cancer type, current age, and treatment status were not associated with caregiver vaccination status at time of survey completion (p > .05). Too few CCS (5/130, 4%) had themselves been vaccinated to perform regression modeling for this outcome. Interrater reliability for free-text response coding was extremely high, at 97% overall. Three primary themes emerged from qualitative anal- Income was modeled as a three-level, ordinal variable. The reported odds ratio (OR) corresponds to each one-unit increase in the variable. c Confidences in response variables were modeled as four-level, ordinal variables. All associations presented are for a model including only the federal government confidence variable, with the exception of associations with the state government confidence variable, which were calculated without the federal government variable in the model due to collinearity. d Includes "child's oncologist," "child life specialist," "hospital's resource center," and "case worker/social worker/counselor." (Table 4) reports that a subset of parents has concerns about long-term effects of COVID-19 vaccination on developing children, but that such concerns may be modified when risk-benefit assessments are made in the context of comorbid chronic conditions, such as those experienced by CCS. [14] [15] [16] Caregivers who expressed higher confidence in the federal and state governments' responses to COVID-19, and those who reported TA B L E 4 Free-text themes with sample corresponding quotes I believe in science. Because I trust his doctors and I believe in science. I'm more afraid of COVID than I am of the vaccine. I trust if medical professionals (and in particular her pediatrician) say it's safe for her, then we will do it. We will defer to the recommendations of her oncologist and endocrinologist, but we hope she is able to get the vaccine to help protect her and the people with whom she comes in contact. We believe vaccines work. I strongly believe in the importance of vaccines. The more we are all vaccinated, the sooner we can get back to normal. I believe in the science behind the vaccine. It is the best protection against the virus. She tends to get sicker than most people when getting virus or bacterial infections, and we worry how her body will be able to fight off the virus if she got it. She has many life-threatening conditions. We are fearful of her ability to fight COVID and want to protect her as best we can. This vaccine was rushed through the approval process and there have been too many adverse effects. The one I am most concerned about is one that affects the blood itself and causes an autoimmune disease. This concerns me because she had a blood cancer and she already has a number of chronic conditions stemming from her cancer and chemo. Just worried it may be too rushed for children. I don't want to mess with her immune system. It hasn't been studied long-term in children and especially not kids with cancer. More information on how it affects children will need to be available before I decide. obtaining COVID-19 information from cancer care professionals, were likelier to report that they would accept the SARS-CoV-2 vaccine for themselves and their CCS. Trust in governments has been identified as a positive predictor of vaccine willingness in the general population for both the SARS-CoV-2 vaccine 6 and other vaccines. 24 Qualitative analysis revealed more explicit concerns related to CCS vaccination, including an appreciation of the more fragile health statuses of CCS and their potential increased risk of experiencing severe COVID-19 complications. These concerns were balanced against the understandable concern that a CCS could potentially also be at greater risk of vaccine-related complications and a desire for more long-term information on vaccine efficacy and safety in the CCS population. Forty-two percent of CCS in our sample had previously participated in an oncology clinical trial, compared with 25%-54% in nationally representative surveys of childhood cancer patients. 19 Given these families' platform may also exclude some potential participants; for example, those who are uncomfortable with electronic surveys or those without electronic access. These further limit the generalizability of our results to the larger CCS population. While discordant perspectives on COVID-19 vaccine acceptability may exist within two-parent households, we were not able to assess this in our dataset; further, the majority of the respondents were female, and additional data are needed to evaluate potential differences related to caregiver sex. Finally, the questions in our survey evaluating vaccine willingness were adapted from a published mixed methods study that had been internally validated, 6 FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine. FDA FDA issues emergency use authorization for third COVID-19 vaccine COVID-19) update: FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic KFF COVID-19 vaccine monitor Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England Chronic comorbidities among survivors of adolescent and young adult cancer The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study Risk and temporal changes of heart failure among 5-year childhood cancer survivors: a DCOG-LATER Study Cardiovascular risk factors in adult survivors of pediatric cancer-a report from the childhood cancer survivor study Pulmonary outcomes in survivors of childhood central nervous system malignancies: a report from the Childhood Cancer Survivor Study Hospitalization rates among survivors of childhood cancer in the Childhood Cancer Survivor Study cohort Hospital-related morbidity among childhood cancer survivors in British Columbia, Canada: report of the Childhood, Adolescent, Young Adult Cancer Survivors (CAYACS) program Attitudes of patients with cancer towards vaccinations-results of online survey with special focus on the vaccination against COVID-19 Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar Caregiver willingness to vaccinate their children against COVID-19: cross sectional survey Caregiver acceptance of an anticipated COVID-19 vaccination Impacts of COVID-19 on caregivers of childhood cancer survivors Childhood cancer: patterns of protocol participation in a national survey Assessment of enrollment characteristics for Children's Oncology Group (COG) upfront therapeutic clinical trials Well-Being of Youth and Emerging Adults Across Cultures: Novel Approaches and Findings from Europe, Asia, Africa and America. Cross-Cultural Advancements in Positive Psychology Codebook development for team-based qualitative analysis Qualitative research: standards, challenges, and guidelines Factors associated with differential uptake of seasonal influenza immunizations among underserved communities during the 2009-2010 influenza season Patient and practice level factors associated with seasonal influenza vaccine uptake among at-risk adults in England Missing the pointhow primary care can overcome Covid-19 vaccine "Hesitancy De-identified, individual-level data are available from the authors upon reasonable request. The authors declare no potential conflicts of interest. Additional supporting information may be found in the online version of the article at the publisher's website.